SlideShare une entreprise Scribd logo
1  sur  12
Biotec Services International Ltd
Vision
“By 2012, Biotec will be the market leader in cold chain pharmaceutical
services, headquartered in the UK with a global presence. We will achieve this
through a highly skilled, motivated team using best practice and technological
advances.”


Mission
We ensure that patients’ and clients’ needs are at the forefront of our business
whether the medicines are for clinical trials or everyday use.
Background                           Core Services
Founded 1997                         QP & GMP Consultancy

Privately owned                      Clinical Supply

Purpose built facility               Unlicensed medicines

Queen’s Award for Enterprise 2009    Marketed Product

Cold chain specialists               Logistics

Fully licensed & inspected by MHRA   Stand-alone storage
Biotec’s wide product experience includes:
• Biopharmaceuticals                   • Small molecules
Monoclonal antibodies                  Oral
Vaccines                               Injectables
Therapeutic proteins                   Topicals
                                       Inhalation products
• Advance Therapy Medicinal products
Stem cells                             •Controlled drugs
Gene therapies                         (schedules 3 and 4)
Tissue Engineered product

• Devices
For patient use
For surgical use
QP & GMP Consultancy
• 6 QPs with wide experience             • Assistance with:
of all core areas                        EU regulatory requirements
• Manufacturing process                  Label text compliance
review and development                   Blinding issues
• Facility development
                                         • Batch certification
• IMPD review
• QP audits and familiarisation visits
for IMP and Marketed Product
importation
Protocol interpretation
                                        for kit design and
                                         supply strategy

Clinical Supply:      Returns and destruction
                                                            IVR and IWR
                                                         controlled studies


                   Global distribution                             Product
                                                               specification file
                    Expiry date                                  (PSF) set up
                     extension
                                                                Randomisation
                                                                schedules and
                    Patient Pack                                decode options
                     assembly


                        Primary packing             Sourcing of comparators
                                                     and ancillary products

                                       Label and leaflet
                                    design, translation and
                                     printing using Prisym
                                           software
Unlicensed medicines
• Management of unlicensed medicines    • Compassionate Use:
(treatment of patients under            Continuation of treatment following
 the responsibility of the physician)   participation in a clinical trial


• Named Patient                         • Biotec can assist with:
UK “Specials” legislation, commonly     Import authorisation
known as “Named Patient”                Labelling and assembly
France – ATU                            QA release
US – expanded access                    Global distribution
Marketed Pharmaceuticals
• Biotec can assist with:                  • Biotec specialises in small batches
Artwork generation                         for niche markets
Multi language label and leaflet design,
                                           • Low temperature
translation and printing
                                           and difficult-to-handle products
Label and assembly
QP certification
Management of invoicing on behalf
of licence holder
Biotec can provide the following Logistics
services (Import and Export services)
• Fully qualified shipping systems        • A range of temperature monitors to suit
for transport of product at:                the specified temperatures
15 to 25ºC
                                          • GMP storage and re-packaging
2 to 8ºC                                    for trans-shipments
-15 to -25ºC
                                          • Product – specific qualification of shippers
-60 to -80ºC
                                            & transport systems to meet individual needs
-140ºC
                                          • A range of specialist courier options
• Preparation of shipping documentation
                                          • Depots for storage and distribution
 Customs invoices
                                            where appropriate
 Shipping declarations
Biotec offers:
• Temperature controlled storage at             • Cold rooms and freezers have
  Controlled ambient (+15 to +25ºC)               back-up condensers
  Refrigerated (+2 to +8ºC)
                                                • Customised non-standard storage
  Frozen (-15 to -25ºC)
                                                  solutions on request
  Ultra-low temp (-80ºC)
  Vapour (-140ºC) or Liquid Nitrogen (-196ºC)   • Available capacity

• All areas fully validated, temperature
  mapped, monitored and linked
  to emergency back-up
Experience
& Excellence:
Tel: +44 1656 750 550

enquiries@biotec-uk.com

www.biotec-uk.com

Contenu connexe

Tendances

Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...MilliporeSigma
 
cGMP Case Study Training
cGMP Case Study TrainingcGMP Case Study Training
cGMP Case Study Trainingguestaa38de
 
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...MilliporeSigma
 
European packaging regulations
European packaging regulationsEuropean packaging regulations
European packaging regulationsMichael Sterling
 
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy
 
InstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP™
 
batch formula record and master formula record
batch formula record and master formula recordbatch formula record and master formula record
batch formula record and master formula recordRashmitaPoojary1
 
Presentation trvx cdmo-v2
Presentation trvx   cdmo-v2Presentation trvx   cdmo-v2
Presentation trvx cdmo-v2targovax2017
 
Cold Chain Storage & Distribution Europe
Cold Chain Storage & Distribution EuropeCold Chain Storage & Distribution Europe
Cold Chain Storage & Distribution EuropeArena International
 

Tendances (12)

Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
 
cGMP Case Study Training
cGMP Case Study TrainingcGMP Case Study Training
cGMP Case Study Training
 
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
 
European packaging regulations
European packaging regulationsEuropean packaging regulations
European packaging regulations
 
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
 
InstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and Labeling
 
batch formula record and master formula record
batch formula record and master formula recordbatch formula record and master formula record
batch formula record and master formula record
 
BMR & MFR
BMR & MFRBMR & MFR
BMR & MFR
 
Presentation trvx cdmo-v2
Presentation trvx   cdmo-v2Presentation trvx   cdmo-v2
Presentation trvx cdmo-v2
 
Master formula record
Master formula recordMaster formula record
Master formula record
 
Cold Chain Storage & Distribution Europe
Cold Chain Storage & Distribution EuropeCold Chain Storage & Distribution Europe
Cold Chain Storage & Distribution Europe
 
IPT Brochure 8-14
IPT Brochure 8-14IPT Brochure 8-14
IPT Brochure 8-14
 

En vedette

INFIN8VENTURES - Digital Agency Presentation
INFIN8VENTURES - Digital Agency PresentationINFIN8VENTURES - Digital Agency Presentation
INFIN8VENTURES - Digital Agency PresentationHussein Hallak
 
ปฎิทินรายเดือน 2017 D2
ปฎิทินรายเดือน 2017 D2ปฎิทินรายเดือน 2017 D2
ปฎิทินรายเดือน 2017 D2Sootthida Junjam
 
Resumen actividad 5.1.1 neae
Resumen actividad 5.1.1 neaeResumen actividad 5.1.1 neae
Resumen actividad 5.1.1 neaeNerea Ia
 
O Monstro das Festinhas
O Monstro das FestinhasO Monstro das Festinhas
O Monstro das FestinhasKathya Jaguar
 
Indo Japan Trade & Investment Bulletine - January-2013
Indo Japan Trade & Investment Bulletine - January-2013Indo Japan Trade & Investment Bulletine - January-2013
Indo Japan Trade & Investment Bulletine - January-2013Corporate Professionals
 
Focus on imports
Focus on importsFocus on imports
Focus on imports9gllc
 
Why to use PHP
Why to use PHPWhy to use PHP
Why to use PHPsammesh30
 
pub_6951_sustainabilityeuropeanhealthsystems
pub_6951_sustainabilityeuropeanhealthsystemspub_6951_sustainabilityeuropeanhealthsystems
pub_6951_sustainabilityeuropeanhealthsystemsPhilip Hines
 
Rock N Roll Collection Elvs Prsly 18
Rock N Roll Collection Elvs Prsly 18Rock N Roll Collection Elvs Prsly 18
Rock N Roll Collection Elvs Prsly 18ForMovieFansOnly
 
Lampiran b-sni-6989.59.2008a
Lampiran b-sni-6989.59.2008aLampiran b-sni-6989.59.2008a
Lampiran b-sni-6989.59.2008aaldibae
 
Case russian venture_industry_-_3_komanda
Case russian venture_industry_-_3_komandaCase russian venture_industry_-_3_komanda
Case russian venture_industry_-_3_komandaEVA
 
Amárach Economic Recovery Index November 2015
Amárach Economic Recovery Index November 2015Amárach Economic Recovery Index November 2015
Amárach Economic Recovery Index November 2015Amarach Research
 
RMA St. Louis - Industrial Market Overview
RMA St. Louis -  Industrial Market Overview RMA St. Louis -  Industrial Market Overview
RMA St. Louis - Industrial Market Overview Dan Dokovic
 
Cropp (Coltures Risks Observation and Prevention Platform)
Cropp (Coltures Risks Observation and Prevention Platform)Cropp (Coltures Risks Observation and Prevention Platform)
Cropp (Coltures Risks Observation and Prevention Platform)Mohamed Elhariry
 

En vedette (20)

INFIN8VENTURES - Digital Agency Presentation
INFIN8VENTURES - Digital Agency PresentationINFIN8VENTURES - Digital Agency Presentation
INFIN8VENTURES - Digital Agency Presentation
 
Prueba
PruebaPrueba
Prueba
 
ปฎิทินรายเดือน 2017 D2
ปฎิทินรายเดือน 2017 D2ปฎิทินรายเดือน 2017 D2
ปฎิทินรายเดือน 2017 D2
 
Resumen actividad 5.1.1 neae
Resumen actividad 5.1.1 neaeResumen actividad 5.1.1 neae
Resumen actividad 5.1.1 neae
 
O Monstro das Festinhas
O Monstro das FestinhasO Monstro das Festinhas
O Monstro das Festinhas
 
Indo Japan Trade & Investment Bulletine - January-2013
Indo Japan Trade & Investment Bulletine - January-2013Indo Japan Trade & Investment Bulletine - January-2013
Indo Japan Trade & Investment Bulletine - January-2013
 
Buatava reunion 2013
Buatava reunion 2013Buatava reunion 2013
Buatava reunion 2013
 
Focus on imports
Focus on importsFocus on imports
Focus on imports
 
Blog Theme
Blog ThemeBlog Theme
Blog Theme
 
Why to use PHP
Why to use PHPWhy to use PHP
Why to use PHP
 
pub_6951_sustainabilityeuropeanhealthsystems
pub_6951_sustainabilityeuropeanhealthsystemspub_6951_sustainabilityeuropeanhealthsystems
pub_6951_sustainabilityeuropeanhealthsystems
 
Rock N Roll Collection Elvs Prsly 18
Rock N Roll Collection Elvs Prsly 18Rock N Roll Collection Elvs Prsly 18
Rock N Roll Collection Elvs Prsly 18
 
Lampiran b-sni-6989.59.2008a
Lampiran b-sni-6989.59.2008aLampiran b-sni-6989.59.2008a
Lampiran b-sni-6989.59.2008a
 
леся українка
леся українкалеся українка
леся українка
 
Case russian venture_industry_-_3_komanda
Case russian venture_industry_-_3_komandaCase russian venture_industry_-_3_komanda
Case russian venture_industry_-_3_komanda
 
Amárach Economic Recovery Index November 2015
Amárach Economic Recovery Index November 2015Amárach Economic Recovery Index November 2015
Amárach Economic Recovery Index November 2015
 
RMA St. Louis - Industrial Market Overview
RMA St. Louis -  Industrial Market Overview RMA St. Louis -  Industrial Market Overview
RMA St. Louis - Industrial Market Overview
 
Cropp (Coltures Risks Observation and Prevention Platform)
Cropp (Coltures Risks Observation and Prevention Platform)Cropp (Coltures Risks Observation and Prevention Platform)
Cropp (Coltures Risks Observation and Prevention Platform)
 
Building Community
Building CommunityBuilding Community
Building Community
 
BDPA Chapter Building Workshop - Week #3
BDPA Chapter Building Workshop - Week #3BDPA Chapter Building Workshop - Week #3
BDPA Chapter Building Workshop - Week #3
 

Similaire à Biotec Presentation Linkedin

Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_rachel
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Ravs100
 
Bilcare GCS Overview
Bilcare GCS OverviewBilcare GCS Overview
Bilcare GCS OverviewBilcare GCS
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012kjwinmill
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012tony_street
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012biotec_fiona
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Ravs100
 
Bilcare gcs leaflet
Bilcare gcs leafletBilcare gcs leaflet
Bilcare gcs leafletBilcareltd
 
Aeroscout Temp
Aeroscout TempAeroscout Temp
Aeroscout TempMarc
 
Phillips Medisize Ireland March 2013
Phillips Medisize Ireland March 2013Phillips Medisize Ireland March 2013
Phillips Medisize Ireland March 2013kevinludlow
 
CRI Company Overview 2012
CRI Company Overview 2012CRI Company Overview 2012
CRI Company Overview 2012jmeinertCRI
 
Acceleration Brochure English
Acceleration Brochure EnglishAcceleration Brochure English
Acceleration Brochure Englishrobbpoe
 
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015Stephen D. Winyard
 
Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016Aniket Manathkar
 
CRI Company Overview 2013 updated 4
CRI Company Overview 2013  updated 4CRI Company Overview 2013  updated 4
CRI Company Overview 2013 updated 4jmeinertCRI
 
LGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma
 
Core rx presentation_2012
Core rx presentation_2012Core rx presentation_2012
Core rx presentation_2012jfd22222
 
Proven Process Medical Devices, Design, Development, Testing, and Manufacture
Proven Process Medical Devices, Design, Development, Testing, and ManufactureProven Process Medical Devices, Design, Development, Testing, and Manufacture
Proven Process Medical Devices, Design, Development, Testing, and ManufactureMichael Kanis
 

Similaire à Biotec Presentation Linkedin (20)

Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Bilcare GCS Overview
Bilcare GCS OverviewBilcare GCS Overview
Bilcare GCS Overview
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Bilcare gcs leaflet
Bilcare gcs leafletBilcare gcs leaflet
Bilcare gcs leaflet
 
Aeroscout Temp
Aeroscout TempAeroscout Temp
Aeroscout Temp
 
Phillips Medisize Ireland March 2013
Phillips Medisize Ireland March 2013Phillips Medisize Ireland March 2013
Phillips Medisize Ireland March 2013
 
CRI Company Overview 2012
CRI Company Overview 2012CRI Company Overview 2012
CRI Company Overview 2012
 
Acceleration Brochure English
Acceleration Brochure EnglishAcceleration Brochure English
Acceleration Brochure English
 
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
 
Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016
 
CRI Company Overview 2013 updated 4
CRI Company Overview 2013  updated 4CRI Company Overview 2013  updated 4
CRI Company Overview 2013 updated 4
 
LGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIs
 
Core rx presentation_2012
Core rx presentation_2012Core rx presentation_2012
Core rx presentation_2012
 
PharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing ServicesPharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing Services
 
Proven Process Medical Devices, Design, Development, Testing, and Manufacture
Proven Process Medical Devices, Design, Development, Testing, and ManufactureProven Process Medical Devices, Design, Development, Testing, and Manufacture
Proven Process Medical Devices, Design, Development, Testing, and Manufacture
 
DCN Company Profile 2015
DCN Company Profile 2015DCN Company Profile 2015
DCN Company Profile 2015
 

Biotec Presentation Linkedin

  • 2. Vision “By 2012, Biotec will be the market leader in cold chain pharmaceutical services, headquartered in the UK with a global presence. We will achieve this through a highly skilled, motivated team using best practice and technological advances.” Mission We ensure that patients’ and clients’ needs are at the forefront of our business whether the medicines are for clinical trials or everyday use.
  • 3. Background Core Services Founded 1997 QP & GMP Consultancy Privately owned Clinical Supply Purpose built facility Unlicensed medicines Queen’s Award for Enterprise 2009 Marketed Product Cold chain specialists Logistics Fully licensed & inspected by MHRA Stand-alone storage
  • 4. Biotec’s wide product experience includes: • Biopharmaceuticals • Small molecules Monoclonal antibodies Oral Vaccines Injectables Therapeutic proteins Topicals Inhalation products • Advance Therapy Medicinal products Stem cells •Controlled drugs Gene therapies (schedules 3 and 4) Tissue Engineered product • Devices For patient use For surgical use
  • 5. QP & GMP Consultancy • 6 QPs with wide experience • Assistance with: of all core areas EU regulatory requirements • Manufacturing process Label text compliance review and development Blinding issues • Facility development • Batch certification • IMPD review • QP audits and familiarisation visits for IMP and Marketed Product importation
  • 6. Protocol interpretation for kit design and supply strategy Clinical Supply: Returns and destruction IVR and IWR controlled studies Global distribution Product specification file Expiry date (PSF) set up extension Randomisation schedules and Patient Pack decode options assembly Primary packing Sourcing of comparators and ancillary products Label and leaflet design, translation and printing using Prisym software
  • 7. Unlicensed medicines • Management of unlicensed medicines • Compassionate Use: (treatment of patients under Continuation of treatment following the responsibility of the physician) participation in a clinical trial • Named Patient • Biotec can assist with: UK “Specials” legislation, commonly Import authorisation known as “Named Patient” Labelling and assembly France – ATU QA release US – expanded access Global distribution
  • 8. Marketed Pharmaceuticals • Biotec can assist with: • Biotec specialises in small batches Artwork generation for niche markets Multi language label and leaflet design, • Low temperature translation and printing and difficult-to-handle products Label and assembly QP certification Management of invoicing on behalf of licence holder
  • 9. Biotec can provide the following Logistics services (Import and Export services) • Fully qualified shipping systems • A range of temperature monitors to suit for transport of product at: the specified temperatures 15 to 25ºC • GMP storage and re-packaging 2 to 8ºC for trans-shipments -15 to -25ºC • Product – specific qualification of shippers -60 to -80ºC & transport systems to meet individual needs -140ºC • A range of specialist courier options • Preparation of shipping documentation • Depots for storage and distribution Customs invoices where appropriate Shipping declarations
  • 10. Biotec offers: • Temperature controlled storage at • Cold rooms and freezers have Controlled ambient (+15 to +25ºC) back-up condensers Refrigerated (+2 to +8ºC) • Customised non-standard storage Frozen (-15 to -25ºC) solutions on request Ultra-low temp (-80ºC) Vapour (-140ºC) or Liquid Nitrogen (-196ºC) • Available capacity • All areas fully validated, temperature mapped, monitored and linked to emergency back-up
  • 12. Tel: +44 1656 750 550 enquiries@biotec-uk.com www.biotec-uk.com